Smartleaf Asset Management
MRVI icon

Smartleaf Asset Management’s Maravai LifeSciences MRVI Stock Holding History

Smartleaf Asset Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$849 Buy
+111
New +$768 ﹤0.01% 3244
2025
Q2 		– Sell
-51
Closed -$120 – 2885
2025
Q1 		$120 Sell
51
-398
-89% -$1.57K ﹤0.01% 2834
2024
Q4 		$2.47K Buy
449
+59
+15% +$380 ﹤0.01% 2475
2024
Q3 		$3.28K Buy
390
+236
+153% +$2.04K ﹤0.01% 2302
2024
Q2 		$1.09K Buy
+154
New +$1.33K ﹤0.01% 2400

Other funds holding MRVI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
General American Investors
General American Investors New York $1.71B AUM 30.1% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Monaco Asset Management
Monaco Asset Management Monaco $818M AUM 32.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Smartleaf Asset Management's MRVI Position: Q3 2026 in Review

Smartleaf Asset Management opened a new position in Maravai LifeSciences (MRVI) in Q3 2026: 111 shares worth $849. The stake represents ﹤0.01% of the portfolio and ranks #3244 among its holdings. This is a return to the name: Smartleaf Asset Management previously reported a position in MRVI as recently as Q1 2025.

Smartleaf Asset Management first reported a position in MRVI in Q2 2024 and has held it in 5 quarters since. The position peaked at $3.28K in Q3 2024. 86 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.

  • Smartleaf Asset Management held 111 shares of Maravai LifeSciences worth $849 as of Q3 2026.
  • Maravai LifeSciences was a new Smartleaf Asset Management position in Q3 2026.
  • Maravai LifeSciences made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #3244 holding.
  • Smartleaf Asset Management first reported a position in Maravai LifeSciences in Q2 2024 and has held it in 5 quarters since.
  • Smartleaf Asset Management's Maravai LifeSciences position peaked at $3.28K in Q3 2024.
  • 86 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.